2023 |
In August 2023, Thyrocare announced that it has achieved National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation for nine additional processing laboratories in Bhopal, Guwahati, Bangalore, Chennai, Patna, Bhubaneswar, Raipur, Lucknow and Ranchi.
PharmEasy is acquiring a majority stake in listed diagnostics firm, Thyrocare Technologies Ltd for $612 million.
In April 2023, Thyrocare has announced the launch of JAANCH, a brand that offers specialised health packages under one roof. Jaanch provides targeted, detailed, and affordable healthcare solutions to all Indians. The brand Jaanch consists of 26 packages under 9 vital specialties that cover heart health, diabetes, thyroid, cancer, sexually transmitted diseases (STDs), women’s reproductive health, skin care, hair fall and fever.
|
2022 |
In March 2022, Thyrocare Technologies announced plans to launch four regional processing labs in the fourth quarter of FY22 in Nagpur, Ranchi, Raipur and Ahmedabad, in addition to two more regional processing labs in Jaipur and Visakhapatnam (Vizag) in March 2022.
|